- Home
- RPRX vs FISV Comparison
RPRX vs FISV Comparison
Compare RPRX & FISV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RPRX | FISV |
|---|---|---|
| Founded | 1996 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.9B | 28.7B |
| IPO Year | 2020 | 1994 |
Fundamental Metrics
Financial Performance| Metric | RPRX | FISV |
|---|---|---|
| Price | $58.55 | $55.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 28 |
| Target Price | $51.40 | ★ $146.17 |
| AVG Volume (30 Days) | 2.9M | ★ 7.5M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.90% | N/A |
| EPS Growth | N/A | ★ 17.84 |
| EPS | 0.71 | ★ 2.24 |
| Revenue | $2,378,193,000.00 | ★ $21,193,000,000.00 |
| Revenue This Year | $38.63 | N/A |
| Revenue Next Year | $4.73 | $3.94 |
| P/E Ratio | $83.41 | ★ $23.02 |
| Revenue Growth | ★ 5.06 | 3.60 |
| 52 Week Low | $34.63 | $47.04 |
| 52 Week High | $60.44 | $70.41 |
Technical Indicators
Market Signals| Indicator | RPRX | FISV |
|---|---|---|
| Relative Strength Index (RSI) | 53.25 | 59.20 |
| Support Level | $55.66 | $52.54 |
| Resistance Level | $58.84 | $56.56 |
| Average True Range (ATR) | 1.42 | 2.30 |
| MACD | -0.11 | 0.02 |
| Stochastic Oscillator | 46.94 | 87.27 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About FISV Fiserv Inc.
Fiserv is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing, for US banks and credit unions, with a focus on small and midsize banks. Following its 2019 merger with First Data, Fiserv also provides payment processing services to merchants. About 10% of the company's revenue is generated internationally.